A major concern for antisense experiments is the prediction of effective oligonucleotide binding sites. We have developed a system to carry out oligodeoxyribonucleotide-RNA and ribozyme-RNA binding experiments in cell extracts to create a protein environment known to directly influence the structure of the mRNA. In these experiments the native, endogenous mRNA is probed using oligodeoxyribonucleotides (ODNs) to identify RNase H-accessible sites. The resulting RNase H-mediated cleavages in the cell extracts were quantified using RT-PCR with fluorescein and rhodamine tagged primers to generate fluorescent products that are analyzed and quantified on an automated DNA sequencer. As a model substrate for testing this system, we have targeted the murine DNA methyltransferase (MTase) mRNA. An ODN binding site in native MTase mRNA was identified that was cleaved by endogenous RNase H with an efficiency of 85% in the extracts. The ODN that was most effective in the cell extracts was also found to provide the best activity in vivo, resulting in a 75-85% reduction of the MTase mRNA. These data support the use of cell extracts and native transcripts to identify antisense and perhaps ribozyme target sites.
INTRODUCTION
Antisense oligodeoxyribonucleotides (ODNs) have been successfully utilized to inhibit expression of a variety of genes (1) (2) (3) . They show potential promise as therapeutic agents for several diseases, including acute chronic leukemias and restenosis (4) . Progress in the design, applications and a summarization of the potential problems of ODNs have been presented in several reviews devoted to antisense ODNs (5) (6) (7) (8) .
For all ODN therapeutic applications, a principle problem is the identification of accessible regions in the target molecule for base pairing and RNase H activity in cells. Secondary and tertiary structures and association with proteins are the major unknown variables for ODN-mRNA interactions (9, 10) . Several approaches have been described to determine the accessibility of a target RNA molecule to antisense or ribozyme inhibitors. One approach uses an in vitro screening assay applying as many antisense ODNs as possible (3) . Another utilizes random libraries of antisense ODNs (11) (12) (13) (14) . The accessible sites can be monitored by RNase H cleavage (13, 15) , which hydrolyzes the RNA sequences in an RNA/DNA hybrid.
A pool of semi-random, chimeric chemically synthesized ODNs have been used to identify accessible sites cleaved by RNase H on an in vitro synthesized target. Primer extension analyses were used to identify these sites in the target molecule (14) . Other approaches for designing antisense targets in RNA are based upon computer assisted folding models for RNA (16, 17) . Several reports have been published on the use of random ribozyme libraries to screen effective cleavage (18) (19) (20) .
In this study we have established a straightforward and simplified approach for mapping ODN binding and RNase H cleavage sites. As our target, we have chosen the mRNA encoding murine DNA methyltransferase (MTase). DNA methylation plays a major role in regulating many biological functions, including gene regulation, cellular differentiation, genomic imprinting and long-term silencing of genes during mammalian development, and is implicated in the multistep processes of carcinogenesis (21, 22) . This makes the MTase an attractive target for antisense inhibition (23) .
The majority (60-80%) of CpG dinucleotides in a vertebrate genome are methylated at the N5 position of cytidine, generating a pattern of methylation that is gene-and cell-specific (24) . Methylation-silenced genes can be reactivated by demethylation with 5-aza-2′-deoxycytidine, an inhibitor of MTase (25) . Reactivation results in changes of cellular phenotypes and provides a rationale for an antisense-based strategy. We chose MTase as a target since we have a long-term interest in regulating MTase expression with ribozymes in transgenic animals. Because MTase mRNA is GC-rich (60-70%), it presents a difficult target for any antisense technology due to many potential secondary structures. As a means of evaluating whether or not antisense oligo molecules can compete with potential structures, we have utilized ODNs in cell extracts to evaluate efficacy in an environment which mimics that of the intact cell.
Using cellular extracts we show that the accessibility of the native RNA transcript to base pairing with antisense oligos and *To whom correspondence should be addressed. Tel: +1 626 301 8360; Fax: +1 626 301 8271; Email: jrossi@coh.org subsequent RNase H cleavage in cell extracts can be used to predict ODN accessibility on the mRNA encoding MTase in vivo.
MATERIALS AND METHODS

Oligodeoxynucleotides
Antisense ODNs and phosphorothioate antisense ODNs were synthesized in the DNA synthesis facility (City of Hope, Duarte, CA). Antisense ODNs used in these studies were as follows: 
In vitro transcriptions
The plasmid pBluescript-MTase containing the murine MTase cDNA was kindly provided by Michael Reed (Beckman Research Institute, City of Hope, Duarte, CA). For run-off transcriptions, pBluescript-MTase was linearized with SalI, phenol extracted and ethanol precipitated. Run-off transcription was performed in 100 µl of a mixture containing 50 ng/µl linearized plasmid DNA, 40 mM Tris-HCl, pH 7.9, 10 mM dithiotreitol (DTT), 6 mM MgCl 2 , 2 mM spermidine, 2 U/µl RNase inhibitor (Promega, Madison, WI), 100 µM rNTPs (Boehringer Mannheim, Mannheim, Germany), 2 µCi/µl [α-32 P]UTP (ICN Pharmaceuticals Inc., Irvine, CA) and 2 U/µl T3 RNA polymerase (Promega). After 1 h incubation at 37_C, 25 U RNase-free DNase I (Boehringer Mannheim) was added and the mixture incubated further for 15 min at 37_C. The transcript was purified on a 6% polyacrylamide gel containing 8 M urea, localized by autoradiography and eluted by crushing the gel slices in 0.5 mM ammonium acetate, 1 mM EDTA, 0.2% SDS. After subsequent phenol extraction, the transcript was concentrated by ethanol precipitation. The RNA was dissolved in sterile water, quantified and stored at -20_C.
Preparation of cellular extracts
The cell extracts used in these studies were originally designed for use as a source of endogenous RNA polymerase III as described originally by Weil et al. (26) and Wu (27) . Preparation of polymerase III extracts from NIH 3T3 cells growing in log phase was carried out as follows. Approximately 8 × 10 7 cells were pelleted and washed twice in phosphate-buffered saline. The pellets were resuspended in twice the volume of the cell pellet of hypotonic swelling buffer (7 mM Tris-HCl, pH 7.5, 7 mM KCl, 1 mM MgCl 2 , 1 mM β-mercaptoethanol) and after 10 min incubation on ice, transferred to a Dounce homogenizer (VWR, San Diego, CA) followed by 20 strokes with a tight pestle B and addition of 1/10th of the final volume of neutralizing buffer (21 mM Tris-HCl, pH 7.5, 116 mM KCl, 3.6 mM MgCl 2 , 6 mM β-mercaptoethanol). The homogenate was centrifuged at 20 000 g for 10 min at 4_C. The supernatants, which are rich in RNA-binding proteins and RNase H activity and contain endogenous mRNAs, were transferred to an Eppendorf tube on ice and used immediately or stored at -70_C in hypotonic buffer containing 45% glycerol.
RNase H digestion of DNA/RNA hybrids with endogenous RNase H 32 P-labeled in vitro transcribed substrate RNA (1 nM) was incubated with different concentrations of antisense ODN (1, 5, 10 and 50 nM; molar ratios 1:1, 1:5, 1:10, 1:50 substrate:ODN). The reactions were carried out in a volume of 10 µl in 40 mM Tris-HCl, pH 7.5, 4 mM MgCl 2 , 1 mM DTT and 1 µl polymerase III extract containing RNase H activity at 37_C for 1 min. Reactions were stopped with loading buffer and loaded onto a 6% polyacrylamide gel containing 8 M urea. Radioactive bands were analyzed and quantified using a PhosphorImager (Molecular Dynamics, Sunnyvale, CA).
ODN-RNA mapping with endogenous RNase H and endogenous methyltransferase mRNA
The RNase H-mediated cleavage experiments were carried out in a total volume of 30 µl, containing 20 µl polymerase III extract, 1 mM DTT, 20-40 U RNase inhibitor (Promega) and 50 nM each of the various antisense ODNs. The ODNs and RNA were incubated for 5-10 min at 37_C and the mixture was then digested with DNase I for 45 min at 37_C followed by phenol extraction and ethanol precipitation. Reverse transcription was performed according to the manufacturer's protocol (Life Technologies, Grand Island, NY) using 50 ng random hexamer primer and 10 U Moloney murine leukemia virus reverse transcriptase. An aliquot (18 µl) of the RT reaction was amplified using the methyltransferase primers Rh-ODNM and ODNM and the remaining aliquot (2 µl) was amplified using the β-actin primers Fl-ODNβ and ODNβ for 1 min at 94_C, 1 min at 50_C and 2 min at 72_C, for 25-28 cycles in a volume of 50 µl. The β-actin product served as an internal standard as well as loading control. Reaction products were analyzed and quantified on an Applied Biosciences Prismt 377 DNA Sequencer using Genescan analysis software v.2.1 (ABI, Weiterstadt, Germany). For a size marker, the Genescan-2500 TAMARA standard (ABI) with molecular lengths (bp) 827, 536, 490, 470, 361, 286, 269, 238, 233, 222, 186, 172, 116, 109, 94 and 37 was utilized.
Cell line and culture conditions
The NIH 3T3 cell line was maintained in Dulbecco's modified Eagle's medium (DMEM; Irvine Scientific, Santa Ana, CA) supplemented with 10% fetal calf serum (FCS; Irvine Scientific), 1 mM L-glutamine and 100 U/ml penicillin/streptomycin. Cells were grown in a 37_C incubator in an atmosphere containing 5% CO 2 .
ODN transfections
NIH 3T3 cell were grown to a density of 10 6 cells/ml in 100 mm dishes in DMEM containing 10% FCS for 24 h. Thereafter, the different fluorescein-labeled antisense phosphorothioate ODNs (0.1 or 1 µM) were transfected using the cationic liposome Lipofectaminet (2 µg/µl; Life Technologies) in Opti-MEM (Life Technologies). After 16 h incubation, the liposome/DNA complexes were removed, DMEM containing 10% FCS was added to the cells and after 8 h cells were transfected again as mentioned above and incubated for another 16 h. Transfected cells were washed with phosphate-buffered saline prior to extracting the RNA. The cellular uptake of the fluorescently labeled ODNs was detected and monitored using a Zeiss Axiovert 135 fluorescence microscope and a DEI-750 video camera from Optronics.
Probe for the RNase protection analysis
To establish a 32 P-labeled probe for the RNase protection analysis the plasmid pBluescript-MTase was digested with ApaI and EcoRI (New England Biolabs, Beverly, MA) and a 385 bp DNA fragment containing the region targeted by the antisense ODNs was cloned in the plasmid pBluescript SK II (Stratagene, Heidelberg, Germany). The plasmid was named pBlue-MTaseCOM and was linearized with EcoRI. Run-off transcription was carried out as described above using T7 RNA polymerase (New England Biolabs) and [α-32 P]UTP. The mixture was digested with 25 U DNase I and gel purified as described above. The homogeneity of the 380 nt long 32 P-labeled probe was checked by gel electrophoresis.
Murine GAPDH was utilized as internal standard and loading control. The linearized plasmid pTRI-GAPDH template DNA was provided in the Direct Protectt kit (Ambion, Austin, TX). Run-off T7 RNA transcription of this plasmid resulted in a 403 nt long 32 P-labeled probe. The homogeneity of this product was also checked by gel electrophoresis. The radioactivity of the probes was measured by scintillation counting (Beckman, Fullerton, CA).
RNA isolation and RNase protection analysis
Total RNAs from NIH 3T3 cells treated with 0.1 or 1.0 µM of the various ODNs were isolated using RNA-STAT-60 solution (Tel-Test B Inc., Friendswood, TX). The RNase protection assay was performed according to the manufacturer's instructions (Direct Protectt; Ambion). Aliquots of 10-15 µg total RNA were combined with 5 × 10 5 c.p.m. methyltransferase probe and a 1:5 dilution of GAPDH probe (10 5 c.p.m.). Protected fragments were separated on a 6% polyacrylamide gel containing 8 M urea and quantified using a PhosphorImager.
RESULTS
Selection of potential ODN cleavage sites in the MTase mRNA
Three potential sites for testing ODN accessibility were chosen based upon the criteria that each ODN spanned a potential hammerhead ribozyme cleavage site (NUX, where N = A, C, G or U and X = A, C or U) and each of these sites had a different predicted secondary structure based upon the mFOLD program of Michael Zuker. The three ODNs were all directed to binding sites downstream of the AUG translational initiation codon and are depicted in Figure 1 along with the mFOLD predicted structure for 600 nt in this region.
RNase H cleavage experiments utilizing in vitro transcribed MTase RNA
As a first test for the accessibility of the three potential ODN sites, a 32 P-labeled in vitro transcript comprising the first 1200 nt of murine MTase was probed with each of the antisense ODNs and sense control ODN followed by treatment with either Escherichia coli derived RNase H or a 1:20 dilution of the cell extracts harboring mammalian RNase H activity.
The reactions of the in vitro transcribed substrate with the various ODNs and RNase H preparations were specific and produced the expected cleavage products (Fig. 2 gives an example). Figure 2 depicts the results obtained from the antisense ODNs AS398 and AS498 as well as the sense ODN used as control (lane 8). Under the conditions utilized, quantative analyses of substrate cleavage following electrophoresis in denaturing polyacrylamide gels revealed a reduction of MTase transcript of 90-95% with ODN AS498, 85% with AS398 and 80% with AS351. Experiments with either the E.coli or cellular extract derived RNase H gave nearly identical results.
Determination of accessible sites using endogenous substrate
An important question is how realistic are in vitro approaches for predicting the efficiencies of ODNs in vivo? To address this question ODN-directed RNase H cleavage was also studied with a native, endogenous message contained within the cell extracts. Utilization of the endogenous message allows evaluation of RNA accessibility in a protein environment which should mimic that of the intracellular milleux, thereby providing a more rigorous assay for detecting accessible sites on the full-length target for ODNs.
To evaluate the reduction of unlabeled endogenous MTase a quantitative RT-PCR reaction was established using fluorescein/ rhodamine-labeled primers. To carry out this assay, the extracts were treated with the various antisense ODNs or a sense control ODN for 5 min at 37_C. This treatment was followed by a DNase I digestion to destroy the antisense and sense ODNs and any residual DNAs in the extract. The remaining RNA was isolated and used as a substrate for reverse transcription and subsequent DNA PCR. The reverse primer used to amplify the MTase mRNA was 5′ tagged with rhodamine. The product from RT-PCR amplification of the MTase mRNA is 610 bp in length. β-Actin mRNA, which is abundant in these extracts, served as internal standard and loading control. The primer set used to amplify the murine β-actin mRNA was described previously by McCarrey et al. (28) with the exception that the second strand primer was 5′ tagged with fluorescein. PCR amplification of this message generates a product of 445 bp. Aliquots (0.5 µl) from the PCR reactions were electrophoresed in a denaturing polyacrylamide gel. The fluorescein and rhodamine tagged products were quantitated via a Genescan analyses (Fig. 3) . Figure 3A depicts the RT-PCR control carried out on RNA isolated from NIH 3T3 cell extract treated with a sense control ODN, which should not reduce the amount of MTase. This was for quantitative comparison with the antisense ODNs. The results of this experiment show the expected products of 610 bp for MTase (the green peak which coincides with the marker of the expected size indicated at the top of Fig. 3A ) and 445 bp for β-actin (the blue peak which coincides with the expected size marker at the top of Fig. 3A) . In contrast, treatment of the cell extract with the ODN AS498 resulted in a significant reduction in the MTase mRNA signal (Fig. 3B) . This reduction is evidenced by the fact that no green peak (610 bp) is visible despite the detection of the β-actin internal standard peak at the expected 445 bp position. Although the green peak is not visible in the scan, Genescan analysis of the electrophoresed PCR products revealed an 85% reduction of MTase mRNA (Table 1) . Using identical Genescan analyses, a 58% reduction of MTase mRNA was observed with the ODN AS398 and a 20% reduction with the ODN AS351 ( Table 1 ). The percent reductions were calculated by normalizng the Genescan values for the 445 bp peak area relative to the 610 bp β-actin peak and 445 bp peak values obtained with the sense and scrambled ODNs. To confirm that the DNase I digestion of the extracts was complete, a PCR reaction was carried out minus the reverse transcriptase step. No signals were obtained for any of the samples. The measurements were repeated twice.
Intracellular activity of ODN targeted to endogenous MTase mRNA
In order to evaluate the relevance of the native message reduction assay with the in vivo application of the antisense ODNs, each of the antisense as well as the control ODNs were transfected into cultured NIH 3T3 cells using a cationic lipid. For these studies, three terminal phosphorothioate groups were added to the 3′-end . An RT-PCR reaction was performed followed by DNA PCR and Genescan analysis. The blue peak (445 nt) corresponding to the β-actin PCR product was used to normalize this experiment with the control experiment shown in (A). No green peak corresponding to the 610 nt MTase PCR product was observed. The red peaks are the TAMARA standards described above.
A B
of the ODNs to increase their intracellular stability. Furthermore, these ODNs were labeled with fluorescein at their 5′-ends to facilitate monitoring of cellular uptake into NIH 3T3 cells. The fluorescein end-labeled phosphorothioate antisense ODNs (0.1 µM) were transiently transfected at two different times into NIH 3T3 cells using the cationic liposome Lipofectaminet as described in Materials and Methods. Visualization of the fluorescently labeled ODN AS498 indicated efficient transfection in NIH 3T3 cells (Fig. 4B) . The other ODNs showed similar uptake patterns (data not presented). Seventy-two hours after the oligos were transferred into the cells, total RNA was isolated and RNase protection assays were carried out to monitor the effect of the ODNs. A 380 nt long in vitro transcribed RNA probe, complementary to 360 nt of the MTase message and covering the sites targeted by the antisense ODNs, was used in the MTase RNase protection. Murine GAPDH was utilized as an internal standard. For this, the antisense RNA probe was a 403 nt transcript and the RNase-protected fragment is 316 nt long. Figure 5 depicts results of the RNase protection assays in monitoring the antisense ODN activities. Cells treated with 0.1 µM of the fluorescein end-labeled antisense ODN AS498 generated a reduction of 70-80% of MTase mRNA, ODN AS398 an ∼30% reduction and no detectable reduction with ODN AS351 when the MTase-protected RNA was standardized with the control ODN results and normalized to the GAPDH message. These results demonstrate that the data obtained from the RNA accessibility mapping experiments in cell extracts corresponds well with in vivo efficacy of the ODNs under study. Importantly, the in vitro RNase H mapping on the in vitro transcribed substrate did not correspond well with either the extract or in vivo ODN targeting. These results demonstrate that the ODN/RNase H targeting on native transcripts in Pol III extracts can be used as a rapid and relatively simple method for identifying accessible sites in vivo. 
A B DISCUSSION
A major need in the antisense and ribozyme fields is that of a quick and reliable assay for detecting optimal hybridization sites in a target RNA molecule. A number of strategies for increasing the effectiveness of antisense ODNs and ribozymes based upon improved targeting strategies have been published (3, 29) . In vitro approaches which utilize random or semi-random libraries of antisense ODNs and RNase H seem to be more useful than computer simulations (14, 19) . Recent observations suggest that annealing interactions of polynucleotides are clearly influenced by RNA binding proteins (30) (31) (32) . It is therefore important to utilize cellular proteins in assays for elucidating target accessibility and nucleic acid hybrid stability.
Our studies take advantage of easily prepared S20-Pol III cell extracts which provide a relevant protein environment for polymerase III transcription (26, 27) and, as we have shown, for studying ODN-target RNA interactions. These extracts are derived from intact cells in which the cellular homogenate is centrifuged at 20 000 g generating a pellet containing mitochondria and large cytoplasmic vesicles and a supernatant with intact polysomal mRNA. In our case, the native MTase message is present in amounts easily detectable by RT-PCR analysis. We find that these cell extracts contain a very potent RNase H activity which greatly facilitates the testing of antisense ODNs. Moreover, preparation of such extracts can be accomplished in a variety of cell types.
The secondary structure predictions for the MTase mRNA (Fig. 1) in the region immediately downstream of the translational initiation codon were calculated using the mFOLD program. The most stable predicted structure suggests poor accessibility for all three antisense ODNs as depicted in Figure 1 . Using an in vitro transcript as a target for the antisense ODNs and RNase H we observed a 95% reduction in intact RNA transcript with the antisense ODN AS498 and an ∼85% reduction with the antisense ODNs AS398 and AS351 (Fig. 2) . In contrast, probing of the native endogenous MTase mRNA with the various antisense ODNs in the Pol III extracts resulted in a significant (∼85%) reduction of intact message with antisense ODN AS498, whereas antisense ODNs AS398 and AS351 resulted in a poorer reduction. In the case of AS351, the reduction was close to the error limits of detection.
The in vivo efficiencies for the antisense ODNs were monitored by RNase protection assays. With antisense ODN AS498 we achieved a significant reduction via this assay, whereas the antisense ODN AS398 resulted in a minor reduction and the ODN AS351 was completely inactive. The observed antisense effects were sequence-specific. Control ODNs with sense or scrambled hybridization arms did not generate a reduction in MTase mRNA.
Our results demonstrate that it is possible to identify accessible hybridization sites in a native mRNA (in this case the MTase mRNA) using the ODN/Pol III extract mapping approach. This same approach has been used for mapping accessible hammerhead ribozyme cleavage sites. The results with the ribozyme mapping show identical cleavage site accessibility with those obtained by oligo mapping (M.Scherr and J.Rossi, unpublished results). Importantly, this ex vivo approach represents a rapid and facile technique for determining effective antisense ODNs.
